IONS
Ionis Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$58.09
−0.07%Leverage
- Debt / equity
- 5.50x
- Net debt / equity
- 4.70x
- Debt / assets
- 0.81x
- Debt / EBITDA
- 0.56x
- Net debt / EBITDA
- 0.48x
Liquidity & coverage
- Current ratio
- 7.88x
- Quick ratio
- 7.72x
- Cash ratio
- 6.50x
- Interest coverage
- -6.65x
- EBITDA / interest
- 48.40x
- Working capital
- $2.2B
Cash & dividend
- FCF / debt
- -0.23x
- Cash flow / debt
- -0.21x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026